GenePlanet

Status

Current portfolio

Investment type

Growth

Investment date

July 2026

Location

Ljubljana, Slovenia

Website

About

GenePlanet is a European genomics and laboratory platform delivering advanced genetic testing and next-generation sequencing (NGS) services worldwide. Over the past 18 years, the company has grown into one of the leading providers of clinical and preventive genomics solutions, now operating in more than 50 countries.

Driven by the expansion of its high-throughput NGS laboratory network and ongoing technological advancement, the company offers a comprehensive portfolio of clinical, research, and preventive genomic solutions, alongside fully integrated end-to-end NGS services for healthcare and research partners globally.

By connecting advanced technology, scientific expertise, and medical insight, GenePlanet enables informed clinical decision-making, personalized healthcare, and advanced disease prevention.

”We believe Europe's next generation of sequencing infrastructure will be built by companies like GenePlanet – ones that combine scientific excellence, business acumen, and entrepreneurial drive to deliver the benefits of genomic-based personalized medicine to patients across the continent.
Victor DecrionManaging Partner at Lauxera